跳转至内容
Merck
所有图片(1)

主要文件

324410

Sigma-Aldrich

Dynasore

≥98% (HPLC), solid, dynamin inhibitor, Calbiochem®

别名:

发动蛋白抑制剂I ,Dynasore

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C18H14N2O4
分子量:
322.31
分類程式碼代碼:
12352200
NACRES:
NA.77

product name

发动蛋白抑制剂I ,Dynasore, The Dynamin Inhibitor I, Dynasore, also referenced under CAS 304448-55-3, controls the biological activity of Dynamin. This small molecule/inhibitor is primarily used for Membrane applications.

品質等級

化驗

≥98% (HPLC)

形狀

solid

製造商/商標名

Calbiochem®

儲存條件

OK to freeze
protect from light

顏色

pale yellow

溶解度

DMSO: 16 mg/mL

運輸包裝

ambient

儲存溫度

2-8°C

InChI

1S/C18H14N2O4/c21-15-6-5-11(7-17(15)23)10-19-20-18(24)14-8-12-3-1-2-4-13(12)9-16(14)22/h1-10,21-23H,(H,20,24)/b19-10+

InChI 密鑰

SYNDQCRDGGCQRZ-VXLYETTFSA-N

一般說明

一种细胞可渗透的缩氨基脲化合物,可抑制发动蛋白1/2(IC50 ~15 µM)和Drp1的GTPase活性,对其他两种小GTPases(MxA和Cdc42)没有显著的影响。Dynasore已被用来阐明发动蛋白在网格蛋白包被的和突触小泡介导的内吞作用中的作用。抑制相对于GTP是非竞争性的,并且抑制剂靶位点可能位于GTPase结构域中。显示抑制从质膜上去除wt和ΔF508-CFTR。

包裝

用惰性气体包装

警告

毒性:环境危害(N)

重構

复溶后,等分并冷冻保存(-20°C)。储备溶液在-20°C下可稳定保存至多3个月。

其他說明

Young, A., et al. 2009.Biochem.J., In press.
Nankoe, S.R., and Sever, S. 2006.Trends Cell Biol.16, 607.
Newton, A.J., et al. 2006.Proc.Natl.Acad.Sci. USA103, 17955.
Macia.E., et al. 2006.Dev.Cell10, 839.
由于该运输中有害物质的性质,您的订单可能需要支付额外的运输费用。某些尺寸的产品可免除其他有害材料的运输费用。请与您当地的销售办事处联系,以获取有关这些费用的更多信息。

法律資訊

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Elsa M Reyes-Reyes et al.
Methods in molecular biology (Clifton, N.J.), 2036, 173-186 (2019-08-15)
Oligonucleotides can be designed or evolved to bind to specific DNA, RNA, protein, or small molecule targets and thereby alter the biological function of the target. The therapeutic potential of oligonucleotides targeted to intracellular molecules will depend largely on their
Alba García-Fernández et al.
Pharmaceutics, 14(7) (2022-07-28)
In this article, we report one of the few examples of nanoparticles capable of simultaneously delivering CRISPR-Cas9 gene-editing machinery and releasing drugs for one-shot treatments. Considering the complexity of inflammation in diseases, the synergistic effect of nanoparticles for gene-editing/drug therapy
Lina Wang et al.
Immunity, 56(2), 272-288 (2023-02-02)
Self-nonself discrimination is vital for the immune system to mount responses against pathogens while maintaining tolerance toward the host and innocuous commensals during homeostasis. Here, we investigated how indiscriminate DNA sensors, such as cyclic GMP-AMP synthase (cGAS), make this self-nonself
Ying Liu et al.
Kidney diseases (Basel, Switzerland), 6(6), 422-433 (2020-12-15)
Levels of urinary microvesicles, which are increased during various kidney injuries, have diagnostic potential for renal diseases. However, the significance of urinary microvesicles as a renal disease indicator is dampened by the difficulty to ascertain their cell source. The aim
Annemiek Dickhout et al.
International journal of molecular sciences, 22(14) (2021-07-25)
The chemokines CCL5 and CXCL4 are deposited by platelets onto endothelial cells, inducing monocyte arrest. Here, the fate of CCL5 and CXCL4 after endothelial deposition was investigated. Human umbilical vein endothelial cells (HUVECs) and EA.hy926 cells were incubated with CCL5

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门